The Jenoptik stock has started a strong recovery rally in the last two months and is currently trading at over 28 euros (as of December 21st, around 12 p.m.). Since the end of October, the paper of the technology company has gained almost 40 percent and on a year-on-year basis the share price has now turned into the plus.

The MDAX company has benefited from the positive overall market in recent weeks. But the nine-month figures presented in November have also convinced investors and analysts. In 2023, sales and EBITDA can increase and the medium-term prospects are also encouraging. Jenoptik’s products are in demand in several growth industries (such as the chip industry).

Jenoptik with overall strong figures after 9 months After 9 months of the current financial year, Jenoptik has reported a weaker order intake compared to the previous year – this dropped by just under 6 percent to 835 million euros. That was it with the „bad“ news. The order backlog was almost 795 million euros at the end of September, sales and profits could increase.

With just under 769 million euros, sales in comparison to the same period of the previous year increased by 10 percent, while EBITDA even increased by just over 21 percent to 143 million euros. For the full year, Jenoptik has confirmed its targets: sales should be between 1.05 and 1.1 billion euros – the EBITDA margin is now seen at the upper end of the previously announced range at 19.5 percent.

Jenoptik also wants to increase sales and margin in the medium term: by 2025, sales should rise to 1.2 billion euros and the EBITDA margin to 21 to 22 percent.

Jenoptik share: reason for optimism in view of the figures for 2023 and medium-term prospects, the share price increase of the Jenoptik share in the last two months is no surprise. The paper has thus made up for the exaggerated price decline between June and October – and in the coming quarters there is still more potential here.

The analysts also see significantly higher target prices for the Jenoptik share. For example, in updated analyses from December from Berenberg Bank (target price 38 euros) or from Hauck & Aufhäuser (target price 40 euros). Only Deutsche Bank currently sees no further price potential in the Jenoptik share and confirmed the target price of 28 euros.